CR
Chris Raymond Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
108%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
85%
Neutral
15%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Consumer Discretionary
Healthcare
Consumer Discretionary
Footwear & Accessories
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $52 |
40%
upside
| 2 | +106% |
0
%
| 18 Feb ‘26 15 days ago |
|
|
|
Overweight
Upgraded
| $16 |
141%
upside
| 3 | -5% |
0
%
| 9 Jan ‘26 1 month ago |
|
|
|
Strong Buy
Initiated
| $25 |
245%
upside
| 1 | -21% |
0
%
| 18 Dec ‘25 2 months ago |
|
|
|
Outperform
Downgraded
| $123 |
122%
upside
| 3 | +48% |
0
%
| 14 Nov ‘25 3 months ago |
|
|
|
Strong Buy
Initiated
| $13 |
180%
upside
| 1 | -1.7% |
0
%
| 21 Oct ‘25 4 months ago |
|
|
|
Strong Buy
Initiated
| $29 |
291%
upside
| 1 | -10% |
0
%
| 21 Oct ‘25 4 months ago |
|
|
|
Overweight
Maintained
| $284 |
20%
upside
| 1 | +2.4% |
0
%
| 10 Oct ‘25 4 months ago |
|
|
|
Strong Buy
Initiated
| $45 |
30%
upside
| 1 | +36% |
0
%
| 3 Sep ‘25 6 months ago |
|
|
|
Strong Buy
Initiated
| $35 |
1%
downside
| 1 | +181% |
0
%
| 3 Sep ‘25 6 months ago |
|
|
|
Outperform
Initiated
| $105 |
2%
upside
| 1 | +34% |
0
%
| 3 Sep ‘25 6 months ago |
|
|
|
Strong Buy
Initiated
| $23 |
153%
upside
| 1 | +127% |
0
%
| 3 Sep ‘25 6 months ago |
|
|
|
Strong Buy
Initiated
| $75 |
607%
upside
| 1 | -33% |
0
%
| 3 Sep ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $70 |
40%
downside
| 1 | +1,068% |
0
%
| 23 Jul ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $115 |
39%
downside
| 1 | – |
–
| 29 Apr ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $9 |
311%
upside
| 1 | +111% |
0
%
| 6 Mar ‘25 1 year ago |
|